Home > Cashflow Statement > NATCO PHARMA

NATCO PHARMA
Cash Flow from Operating Activities

    Back to Cashflow Statement
NATCO PHARMA is part of below Screeners ↓
Top Small Cap Stocks with Best Fundamentals
Top Undervalued Small Cap Stocks
COMMUNITY POLL
for NATCO PHARMA
Please provide your vote to see the results

NATCO PHARMA Last 5 Year Cash Flow from Operating Activities History

[Consolidated]

Mar2024Mar2023Mar2022Mar2021Mar2020
Cash Flow from Operating Activities ₹1,212 Cr₹849 Cr₹47 Cr₹299 Cr₹417 Cr

What is the latest Cash Flow from Operating Activities ratio of NATCO PHARMA ?

The latest Cash Flow from Operating Activities ratio of NATCO PHARMA is ₹1,212 Cr based on Mar2024 Consolidated results.
Year Cash Flow from Operating Activities
Mar2024₹1,212 Cr
Mar2023₹849 Cr
Mar2022₹47 Cr
Mar2021₹299 Cr
Mar2020₹417 Cr

How is Cash Flow from Operating Activities of NATCO PHARMA Trending?

Years Cash Flow from Operating Activities % Change
Mar2024 ₹1,212 Cr
42.69
Mar2023 ₹849 Cr
1,726.02
Mar2022 ₹47 Cr
-84.44
Mar2021 ₹299 Cr
-28.40
Mar2020 ₹417 Cr -

Compare Cash Flow from Operating Activities of peers of NATCO PHARMA

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
NATCO PHARMA ₹15,070.4 Cr -5.8% 3.6% -13.6% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹438,778.0 Cr 1.4% 4.1% 18.7% Stock Analytics
DIVIS LABORATORIES ₹161,949.0 Cr -2.1% 4.2% 59.1% Stock Analytics
CIPLA ₹123,222.0 Cr -0.1% 5% 9.7% Stock Analytics
TORRENT PHARMACEUTICALS ₹110,205.0 Cr -0.3% 3% 23.4% Stock Analytics
DR REDDYS LABORATORIES ₹98,707.7 Cr -1.5% 1.7% -5.4% Stock Analytics


NATCO PHARMA Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
NATCO PHARMA

-5.8%

3.6%

-13.6%

SENSEX

0.9%

4.2%

8.3%


You may also like the below Video Courses